Karyopharm Therapeutics Inc.

KPTI·NasdaqGS·Healthcare
Compare
0.0729−0.0154 (−17.44%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market0.0713−0.0016 (−2.19%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0883
Open0.0810
Day range0.07290.1268
52-week range0.072910.9900
Off day high−42.51%
Off 52-week high−99.34%
Volume39.24M
Avg. volume (3M)3.44M
Market cap1.65M
EPS (TTM)-14.33
Forward P/E-0.03
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.21
Shares outstanding22.68M
Short interest32.20% of float
Earnings dateAug 13, 2026 (est.)
Analyst target7.2500
Profit margin−153.28%

Against its peers

Compare in full ›
KPTI XBIO CLRB NOX.AX RKV.V ATNM
Market cap 1.65M 4.71M 11.63M 10.75M 4.27M 44.33M
P/E (TTM) — — — — — 3.9
Forward P/E 0.0 -3.0 -0.6 — — -2.7
Price/book 0.0 0.8 0.3 -2.9 -2.0 1.5
Dividend yield — — — — — —
1-year change −98.36% −26.10% −64.14% −64.00% +2.94% +4.48%
Today −17.44% −3.37% −6.11% −2.78% 0.00% +0.71%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Karyopharm Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Xenetic Biosciences, Inc.XBIO · Biotechnology 4.71M 2.0100 −3.37%
Cellectar Biosciences, Inc.CLRB · Biotechnology 11.63M 1.2300 −6.11%
Noxopharm LimitedNOX.AX · Biotechnology 10.75M 0.0350 −2.78%
Rakovina Therapeutics Inc.RKV.V · Biotechnology 4.27M 0.1750 0.00%
Actinium Pharmaceuticals, Inc.ATNM · Biotechnology 44.33M 1.4100 +0.71%
Aptevo Therapeutics Inc.APVO · Biotechnology 2.90M 1.3700 +0.74%
Acrivon Therapeutics, Inc.ACRV · Biotechnology 74.56M 1.7400 +4.19%
Scancell Holdings plcSCLP.L · Biotechnology 116.66M 85.99 +1.16%

Also based in Newton, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Bright Horizons Family Solutions Inc.BFAM · Newton, MA 2.69B 56.22 +5.60%
Diversified Healthcare TrustDHC · Newton, MA 1.79B 7.37 −2.38%
Service Properties TrustSVC · Newton, MA 813.32M 6.28 +1.13%
Industrial Logistics Properties TrustILPT · Newton, MA 431.37M 6.44 0.00%
Office Properties Income TrustOPI · Newton, MA 285.62M 13.01 +0.27%
The RMR Group Inc.RMR · Newton, MA 285.24M 16.70 +0.54%
TechTarget, Inc.TTGT · Newton, MA 252.44M 3.4900 +4.49%
Seven Hills Realty TrustSEVN · Newton, MA 157.95M 6.92 +4.22%

What visitors to Karyopharm Therapeutics's page also look at.

Company Mkt cap Price Today
MacroGenics, Inc.MGNX 147.15M 2.3100 −0.86%
Heron Therapeutics, Inc.HRTX 56.69M 0.2986 +4.88%
Kyntra Bio, Inc.KYNB 16.03M 3.9600 −8.12%
Atara Biotherapeutics, Inc.ATRA 84.02M 8.37 +2.07%
TG Therapeutics, Inc.TGTX 9.43B 61.63 +1.45%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All KPTI news ›
PharmExec··4 outletsNegative

Karyopharm Enters Chapter 11 in Planned Merger With Ayrmid

Karyopharm filed for Chapter 11 under a plan to merge with Ayrmid, with competing bids allowed and closing targeted for the first quarter of 2027. The company will seek court approval of bidding procedures that allow other parties to…

KPTIFMFC
More from 3 other outlets
BioPharma Dive·Negative

Karyopharm, deep in debt, to sell itself in bankruptcy

The parent of cell therapy maker Gamida Cell will be the lead bidder in a court-supervised auction of Karyopharm, which recently cut a forbearance deal to push off debt payments. Karyopharm was able to beat the odds in biotech by bringing…

KPTI
Seeking Alpha·Negative

Karyopharm files bankruptcy, to merge with Ayrmid

Karyopharm Therapeutics plans bankruptcy and a merger with Ayrmid, backed by $55M in financing. - Karyopharm Therapeutics (KPTI) said on Monday that it will file for bankruptcy and merge with Ayrmid. - In connection with this process,…

KPTI
Stock Titan·Negative

Merlin: Inflection Point reports 9.9% ownership

A 9.9% ownership cap excludes 1.395M shares from an investor’s Merlin (MRLN) stake report. Stock Titan - [SCHEDULE 13G] Merlin, Inc. Passive Investment Disclosure (>5%) Merlin: Inflection Point reports 9.9% ownership The 9.9% ownership…

KPTIIPHXWSCHL
Stock Titan·

Karbon-X: Morsevo reports 6.7% common-share stake

Karbon-X Corp. (KARX) is a vertically integrated climate solutions company managing carbon projects, trading, and emissions services across global markets. - [SCHEDULE 13D/A] Karbon-X Corp. Amended Major Shareholder Report Karbon-X:…

KPTIKLXE

From the 4Search news index, newest first.

In the news

16mentions in 30 days
4with it in the headline
Mixedsentiment

Mentioned with

Karyopharm Therapeutics Inc.14Karyopharm Therapeutics Inc10Karyopharm8Wells Avenue8AI Data Centers Across the Nordics6Kymera Therapeutics6Fully Diluted Company Capitalization5Pyrophyte Acquisition Corp5

People in the coverage

Anders Hove13Ayrmid10Karyopharm10Richard Paulson9Pyrophyte7Akzonobel6

Themes

SEC Filings15Biotechnology14Healthcare148-K8Bankruptcy5Kymr5Akzonobel4Beneficial Ownership4

Most coverage from

  1. stocktitan.net4
  2. prnewswire.com2
  3. biopharmadive.com1
  4. biospace.com1
  5. investors.karyopharm.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance